Autoimmunity in Retinitis Pigmentosa

Semmelweis University

Overview

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Masking

NONE

Conditions

Retinitis Pigmentosa

Interventions

twice-daily dosage with 0.5% cyclosporine-A eyedropsDRUG

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical diagnosis of retinitis pigmentosa Exclusion Criteria: * Cataract * Extremely low ERG wave amplitude (less than 8% of normal)

Locations (1)

Semmelweis University, Dept. of Ophthalmology

Budapest, Hungary

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.